Concord Medical Services Holdings Ltd. - Sponsored ADR
Price
Key statistics
- Forward rate
- $0.00
- Yield
- 0.00%
- Payout ratio
- 0.00%
- Frequency
- Unknown
- 2015-12-23$9.80
Concord Medical Services Holdings Ltd. is an asset in the form of a Sponsored American Depositary Receipt (ADR). Its primary function is to offer investors in the United States exposure to the healthcare sector in China, specifically in the specialized areas of radiotherapy and diagnostic imaging centers. Concord Medical is headquartered in China and focuses on providing a range of healthcare services and products through an extensive network of specialized cancer hospitals and treatment centers. By utilizing the ADR mechanism, the company allows U.S. investors to purchase shares that correspond to the foreign equities which are traded on American stock exchanges, simplifying the process of investing in foreign companies. This asset plays an important role in diversifying investment portfolios by granting American investors access to growth opportunities in China's burgeoning healthcare industry, particularly as it pertains to advanced cancer treatment and diagnostic services. Concord Medical Services Holdings Ltd.'s presence in the financial markets underscores the integration and collaboration between U.S. and Chinese markets, contributing to a global investment landscape.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- CEO
- Dr. Jianyu Yang
- Employees
- 610
- Headquarters
- Beijing, China
- Website
- www.concordmedical.com